Tag: Chronic hepatitis b

Clinical studies indicate that the most common side effects associated with tenofovir alafenamide, the active ingredient in Tafnat 25 mg, include headache, nausea, and fatigue. This article explores **what are the side effects of Tafnat 25 mg**, detailing both the common and rare adverse effects, and providing essential information for patient safety.

According to the World Health Organization's 2024 guidelines, for most individuals with chronic hepatitis B, nucleoside analogue treatment with tenofovir or entecavir is highly effective. There is no single universal "best" medicine for chronic hepatitis B, but expert guidelines prioritize certain treatments based on potency, safety, and resistance profiles.

Currently, there is no definitive sterilizing cure for chronic hepatitis B (CHB), and while tenofovir is a highly effective treatment, it does not achieve complete viral eradication for most patients. Instead, it functions as a potent antiviral to manage the infection over the long term.

Telbivudine, an antiviral agent once branded as Tyzeka in the United States, demonstrated significantly greater antiviral activity and less resistance compared to lamivudine in its initial clinical trials for treating chronic hepatitis B. This medication was developed to suppress the hepatitis B virus (HBV) and mitigate liver damage in infected individuals.